[1]
“Topical calcipotriol versus oral psoralen-UVA (PUVA) and topical calcipotriol in the treatment of vitiligo in type IV skin”, J Pak Assoc Dermatol, vol. 17, no. 2, pp. 89–94, Dec. 2016, doi: 10.66344/jpad.17.2.2007.693.